Literature DB >> 3421965

Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain.

T Sudoh1, N Minamino, K Kangawa, H Matsuo.   

Abstract

Brain natriuretic peptide (BNP) is a newly identified peptide of 26 residues, which has a remarkable homology to but is distinct from atrial natriuretic peptide. The peptide exerts natriuretic-diuretic activity as well as potent chick rectum relaxant activity. By using radioimmunoassay specific to BNP and immunoaffinity chromatography, we have isolated from porcine brain a novel peptide of 32 residues carrying a BNP structure at the C-terminus. The amino acid sequence of this peptide was determined to be: Ser-Pro-Lys-Thr-Met- Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly- Leu- Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr. This peptide is an N-terminal six amino acid extended form of BNP and henceforth is designated BNP-32. BNP and BNP-32 are found to be major forms of BNP family in porcine brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421965     DOI: 10.1016/s0006-291x(88)80555-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Does the relationship between natriuretic hormones and diastolic function differ by race?

Authors:  Gaston K Kapuku; Harry C Davis; Patrick Thomas; James Januzzi; Gregory A Harshfield
Journal:  Am J Med Sci       Date:  2012-08       Impact factor: 2.378

Review 2.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

Review 3.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

4.  The relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findings.

Authors:  Shinji Fukazawa; Koji Teruya; Takamoto Uemura; Tomoko Omine; Tomoko Matsui; Nobuo Takeda; Hiroteru Okamoto; Kaoru Ichikawa; Kosuke Tsuchida; Rieko Takemae; Momoo Matsuda; Tooru Tsunoda
Journal:  Environ Health Prev Med       Date:  2008-04-04       Impact factor: 3.674

Review 5.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

Review 6.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

7.  Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?

Authors:  A D Struthers
Journal:  Br Heart J       Date:  1993-11

8.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

9.  Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension.

Authors:  J Marcil; M B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

10.  Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation.

Authors:  Kailash N Pandey
Journal:  J Am Soc Hypertens       Date:  2008 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.